Vicarious Surgical''s Beta 2 system is complete and is now working toward its next system, v1.0. Click here to read my thoughts on RBOT stock.

The Dow Jones closed lower by over 400 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company''s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga''s insider transactions platform. Arlo Technologies The Trade: Arlo Technologies Inc (NYSE: ARLO ) Director Grady Summers bought a total of 3,497 shares at an average price of $4.27. To acquire these shares, … Full story available on Benzinga.com

MedTech firm Vicarious Surgical (RBOT) added ~7% Tuesday after the company announced cost-cutting measures, including layoffs with its Q4 2022 results. Read the full story here.

BOULDER, CO / ACCESSWIRE / February 14, 2023 / Encision Inc. (PK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM ® ) Technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, today announced that Encision has signed a Proof of Concept Services Agreement ("Agreement") with Vicarious Surgical Inc. ("Vicarious Surgical"). The Vicarious Surgical robot design intends to maximize visualization, precision, and control of instruments in robotic-assisted minimally invasive surgery. "We are happy to be teaming up with Vicarious Surgical to drive new levels of patient safety in robotic surgery. Encision''s Active Electrode Monitoring is a proprietary and differentiated technology that shields patients and practitioners from radiant energy injuries during standard and robotic laparoscopic surgeries. We welcome this initial phase of our relationship," said Gregory J. Trudel, President and CEO of Encision. Encision Inc. designs and markets a portfolio of high-performance surgical instrumentation that delivers advances in patient safety with AEM Technology, surgical performance, and value to hospitals across a broad range of minimally invasive surgical procedures.

Vicarious Surgical, Inc. (NYSE:NYSE:RBOT) Q4 2022 Earnings Conference Call February 13, 2023 4:30 PM ETCompany ParticipantsKaitlyn Brosco - IRAdam Sachs - Co-Founder, CEO, President &…

Vicarious Surgical press release (NYSE:RBOT): Q4 Non-GAAP EPS of -$0.16 beats by $0.02.

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced financial results for the quarter and full year ended December 31, 2022. Management will host a corresponding conference call at 4:30 p.m. ET today, February 13, 2023. “2022 was a transformational year for Vicarious S

Vicarious Surgical (NYSE: RBOT ) is set to give its latest quarterly earnings report on Monday, 2023-02-13. Here''s what investors need to know before the announcement. Analysts estimate that Vicarious Surgical will report an earnings per share (EPS) of $-0.17. Vicarious Surgical bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the … Full story available on Benzinga.com

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the fourth quarter and full year ended December 31, 2022 after the market closes on Monday, February 13, 2023. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Inve